GPT and tuberculosis: Sixteen patients with DIH due to anti-tuberculosis treatment reported a change in mean value from 202 U/L to 61 U/L or a reduction of 141 U/L (70%) in mean ALT levels from baseline within 2-3 weeks (P<0.0001), indicating the preliminary trend of the efficacy of the study drug within 2-3 weeks in this subgroup.